Efficacy and Influencing Factors of Allogeneic Hematopoietic Stem Cell Transplantation in Treatment of 71 Children with Leukemia

Overview

Journal Chin Med J (Engl)

Specialty General Medicine

Date 2019 Mar 22

PMID 30897600

Authors

Bing-Lei Zhang

Jian Zhou

Tian-Xi Lyu

Rui-Rui Gui

Ying-Ling Zu

Feng-Kuan Yu

Hui-Fang Zhao

Zhen Li

Juan Wang

Yan-Li Zhang

Wen-Lin Zhang

Yue-Wen Fu

Xu-Dong Wei

Bai-Jun Fang

Yu-Fu Li

Ke-Shu Zhou

Yong-Ping Song

Affiliations

Soon will be listed here.

References

Cornelissen J, Gratwohl A, Schlenk R, Sierra J, Bornhauser M, Juliusson G . The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol. 2012; 9(10):579-90. DOI: 10.1038/nrclinonc.2012.150. View

Gutierrez-Aguirre C, Gomez-De-Leon A, Alatorre-Ricardo J, Cantu-Rodriguez O, Gonzalez-Llano O, Jaime-Perez J . Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?. Transfusion. 2014; 54(5):1269-77. DOI: 10.1111/trf.12466. View

Cornelissen J, Versluis J, Passweg J, van Putten W, Manz M, Maertens J . Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia. 2014; 29(5):1041-50. DOI: 10.1038/leu.2014.332. View

Sahin U, Toprak S, Ataca Atilla P, Atilla E, Demirer T . An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016; 22(8):505-14. DOI: 10.1016/j.jiac.2016.05.006. View

Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle J, Cornish J . Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow.... Biol Blood Marrow Transplant. 2016; 23(3):467-474. DOI: 10.1016/j.bbmt.2016.11.022. View

Xu L, Chen H, Chen J, Han M, Huang H, Lai Y . The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol. 2018; 11(1):33. PMC: 5833104. DOI: 10.1186/s13045-018-0564-x. View

Shim Y, Lee J, Kim H, Jung N, Lim Y, Yang E . Comparison of survival outcome between donor types or stem cell sources for childhood acute myeloid leukemia after allogenic hematopoietic stem cell transplantation: A multicenter retrospective study of Study Alliance of Yeungnam Pediatric.... Pediatr Transplant. 2018; :e13249. DOI: 10.1111/petr.13249. View

Tomizawa D, Yoshida M, Kondo T, Miyamura T, Taga T, Adachi S . Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases. Bone Marrow Transplant. 2018; 54(3):393-401. DOI: 10.1038/s41409-018-0273-7. View

Erdmann F, Li T, Luta G, Giddings B, Torres Alvarado G, Steliarova-Foucher E . Incidence of childhood cancer in Costa Rica, 2000-2014: An international perspective. Cancer Epidemiol. 2018; 56:21-30. DOI: 10.1016/j.canep.2018.07.004. View

10.

Ciftciler R, Demiroglu H, Buyukasik Y, Aladag E, Aksu S, Haznedaroglu I . Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2019; 19(3):177-182. DOI: 10.1016/j.clml.2018.11.016. View